Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
CALL
Crown Holdings
CCK
$12.9B
| $4.51M | ﹤0.01% |
48,900
-11,400
| -19% | -$1.22M |
|
|
LOVE
3902
CALL
LoveSac
LOVE
$253M
| $4.51M | ﹤0.01% |
163,900
+106,600
| +186% | +$4.14M |
|
3903
PUT
iShares Core S&P Mid-Cap ETF
IJH
$129B
| $4.5M | ﹤0.01% |
99,500
+68,000
| +216% | +$3.36M |
|
3904
PUT
Bread Financial
BFH
$4.58B
| $4.5M | ﹤0.01% |
121,400
-51,500
| -30% | -$2.62M |
|
3905
Smith & Nephew
SNN
$12.5B
| $4.5M | ﹤0.01% |
161,109
-111,483
| -41% | -$3.47M |
|
|
AVAN
3906
DELISTED
Avanti Acquisition Corp.
AVAN
| $4.5M | ﹤0.01% |
453,643
-1,538,096
| -77% | -$15.2M |
|
|
DCH
3907
CALL
Dauch Corp
DCH
$1.6B
| $4.5M | ﹤0.01% |
597,000
+519,900
| +674% | +$3.91M |
|
|
SAFE
3908
Safehold
SAFE
$1.08B
| $4.49M | ﹤0.01% |
67,317
+9,353
| +16% | +$788K |
|
3909
PUT
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.3B
| $4.49M | ﹤0.01% |
257,000
-10,900
| -4% | -$205K |
|
3910
CALL
Invesco S&P 500 Low Volatility ETF
SPLV
$7.23B
| $4.49M | ﹤0.01% |
72,400
+33,500
| +86% | +$2.17M |
|
3911
CALL
Icon
ICLR
$12.6B
| $4.49M | ﹤0.01% |
20,700
-10,800
| -34% | -$2.42M |
|
3912
CALL
Herbalife
HLF
$1.29B
| $4.49M | ﹤0.01% |
219,300
+36,500
| +20% | +$902K |
|
|
MRTX
3913
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.48M | ﹤0.01% |
66,800
+15,500
| +30% | +$986K |
|
|
HSKA
3914
DELISTED
Heska Corp
HSKA
| $4.48M | ﹤0.01% |
47,446
-6,662
| -12% | -$719K |
|
|
HOLX
3915
CALL
DELISTED
Hologic
HOLX
| $4.48M | ﹤0.01% |
64,600
-44,400
| -41% | -$3.3M |
|
|
NKLA
3916
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
| $4.48M | ﹤0.01% |
31,343
-8,750
| -22% | -$1.79M |
|
3917
CALL
Extra Space Storage
EXR
$31.2B
| $4.47M | ﹤0.01% |
26,300
-15,800
| -38% | -$2.93M |
|
3918
Zimmer Biomet
ZBH
$19.2B
| $4.47M | ﹤0.01% |
+42,583
| New | +$5.05M |
|
|
FYBR
3919
CALL
DELISTED
Frontier Communications
FYBR
| $4.47M | ﹤0.01% |
190,000
+74,300
| +64% | +$1.9M |
|
3920
Vanguard US Value Factor ETF
VFVA
$945M
| $4.47M | ﹤0.01% |
+48,970
| New | +$4.95M |
|
3921
Cactus
WHD
$5.88B
| $4.47M | ﹤0.01% |
111,014
+80,932
| +269% | +$4.07M |
|
3922
Kaiser Aluminum
KALU
$2.97B
| $4.46M | ﹤0.01% |
56,366
+51,971
| +1,183% | +$4.86M |
|
3923
PUT
Vanguard Morningstar Value ETF
VTV
$194B
| $4.46M | ﹤0.01% |
33,800
+7,600
| +29% | +$1.07M |
|
3924
CALL
PTC
PTC
$16.2B
| $4.46M | ﹤0.01% |
41,900
+11,900
| +40% | +$1.28M |
|
3925
Neogen
NEOG
$2.54B
| $4.45M | ﹤0.01% |
184,890
+144,765
| +361% | +$3.88M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.